The federal government plans to give the exclusive license for a new liver cancer drug to a pharmaceutical company owned by Chinaâs 63rd-richest man, HuffPost has learned. The National Institutes of Health proposes to grant Salubris Biotherapeutics, Inc. exclusive worldwide rights to a portfolio of patents on antibody drugs used to treat liver cancer, according to a notice published Monday on the Federal Register.
Vitamin A deficiency is the leading cause of preventable childhood blindness and is critical to achieving Millennium Development Goal 4:2 to reduce child mortality.revalence of vitamin A deficiency. Vitamin A deficiency (VAD) is a lack of vitamin A in humans. It is common in poorer countries but rarely seen in more developed countries. Nyctalopia (night blindness) is one of the first signs of VAD.
Vitamin A is also used for shigellosis, diseases of the nervous system, nose infections, loss of sense of smell, asthma, persistent headaches, kidney stones, overactive thyroid, iron-poor blood (anemia), deafness, ringing in the ears, and precancerous mouth sores (leukoplakia).iver disease: Too much vitamin A might make liver disease worse. Do not take vitamin A if you have liver disease. Malnutrition: In people with severe protein malnutrition, taking vitamin A might result in having too much vitamin A in the body.